Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Clin Dermatol. 2012 Jan-Feb;30(1):103-7. doi: 10.1016/j.clindermatol.2011.03.016.

Quality of life in patients with bullous dermatoses.

Author information

  • 1Department of Dermatology, St. George Hospital, University of New South Wales, Kogarah, Australia. d.murrell@unsw.edu.au

Abstract

Genetic and acquired bullous dermatoses can severely affect multiple domains of a patient's quality of life (QOL). Integrating formal evaluation of QOL into the clinical evaluation of patients facilitates an objective assessment of disease severity, mapping of disease trajectory, and captures therapeutic intervention outcomes. There have been 5 studies evaluating QOL in autoimmune dermatoses and 4 studies reviewing QOL in the genodermatoses. All literature to date indicates a significant disease burden in this setting. The development of formal QOL instruments has facilitated quantification of QOL deficits in this arena and offers promising tools for patient assessment in the future.

Copyright © 2012 Elsevier Inc. All rights reserved.

PMID:
22137233
[PubMed - indexed for MEDLINE]
PMCID:
PMC3883428
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk